Diagnos Laboratorium Utama Tbk. vs Bima Sakti Pertiwi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Bima Sakti Pertiwi Tbk. trades at Rp52 (market cap 162.5B, 2.57M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Bima Sakti Pertiwi Tbk. is more actively traded (2.57M versus 129.6K). Which is the better fit depends on your goals.
| DGNS | PAMG | |
|---|---|---|
Market Cap | 308B | 162.5B |
Volume | 129.6K | 2.57M |
Lot | 1.3K | 25.72K |
Turnover | 28.71M | 130.93M |
Average Price | 221.54 | 50.9 |
Value | 28.71M | 130.93M |
Indicative Equilibrium Price | 230 | 52 |
Indicative Equilibrium Volume | 110 | 23 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bima Sakti Pertiwi Tbk (the Company) was established based on the Notarial Deed of Raden Minarno Hardjokoesoemo, S.H., Deputy Notary in Tanjungpinang, No. 30, dated April 28, 1980.
Read more on PAMG →